Tech Company Financing Transactions

Xeris Pharmaceuticals Funding Round

Redmile Group, ASAHI Net and Bay City Capital joined a $30 million Series C funding round for Xeris Pharmaceuticals. The round closed on 5/20/2017.

Transaction Overview

Announced On
5/20/2017
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series C
Proceeds Purpose
The proceeds from this financing will be used to advance the phase 3 clinical development and NDA submission of Xeris' liquid stable, prefilled, single use, glucagon auto-injector for the treatment of severe hypoglycemia in patients with Type 1 diabetes.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3208 Red River St. 300
Austin, TX 78705
USA
Email Address
Overview
Xeris is an Austin, Texas-based specialty pharmaceutical company developing patient-friendly injectables for indications in diabetes, epilepsy, and immunology.
Profile
Xeris Pharmaceuticals LinkedIn Company Profile
Social Media
Xeris Pharmaceuticals Company Twitter Account
Company News
Xeris Pharmaceuticals News
Facebook
Xeris Pharmaceuticals on Facebook
YouTube
Xeris Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Paul Edick
  Paul Edick LinkedIn Profile  Paul Edick Twitter Account  Paul Edick News  Paul Edick on Facebook
Chief Financial Officer
Barry Deutsch
  Barry Deutsch LinkedIn Profile  Barry Deutsch Twitter Account  Barry Deutsch News  Barry Deutsch on Facebook
Chief Operating Officer
John Shannon
  John Shannon LinkedIn Profile  John Shannon Twitter Account  John Shannon News  John Shannon on Facebook
Chief Scientific Officer
Steven Prestrelski
  Steven Prestrelski LinkedIn Profile  Steven Prestrelski Twitter Account  Steven Prestrelski News  Steven Prestrelski on Facebook
Vice President
Allison Wey
  Allison Wey LinkedIn Profile  Allison Wey Twitter Account  Allison Wey News  Allison Wey on Facebook
VP - General Counsel
Beth Hecht
  Beth Hecht LinkedIn Profile  Beth Hecht Twitter Account  Beth Hecht News  Beth Hecht on Facebook
VP - Regulatory Affairs
Ken Johnson
  Ken Johnson LinkedIn Profile  Ken Johnson Twitter Account  Ken Johnson News  Ken Johnson on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/20/2017: Affinity venture capital transaction
Next: 5/22/2017: ABS Entertainment Payroll venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary